Drug manufacturers are fighting mad about pricing legislation and they're taking the next round public
While drug pricing reform is snaking its way through Congress, the proposed legislation is facing some opposition from industry groups, as the National Association of Manufacturers is taking the fight to the airwaves.
The trade group, the National Association of Manufacturers (NAM), has released a 30-second ad that firmly opposes price controls, calling them a “hidden tax on manufacturers that harms innovation, competitiveness and R&D investments in new cures.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.